Exportar registro bibliográfico


Metrics:

ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice (2018)

  • Authors:
  • USP affiliated authors: EVANGELISTA, FABIANA DE SANT'ANNA - EACH
  • Unidades: EACH
  • DOI: 10.6061/clinics/2018/e246
  • Subjects: SISTEMA NERVOSO; ANGIOTENSINAS
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Clinics
    • ISSN: 1807-5932
    • Volume/Número/Paginação/Ano: v. 73, p. 01-06, 2018
  • Online source accessDOI
    Informações sobre o DOI: 10.6061/clinics/2018/e246 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MORAES, Oscar Albuquerque de; FLUES, Karin; SCAPINI, Kátia Bilhar; et al. ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice. Clinics, São Paulo, v. 73, p. 01-06, 2018. Disponível em: < http://dx.doi.org/10.6061/clinics/2018/e246 > DOI: 10.6061/clinics/2018/e246.
    • APA

      Moraes, O. A. de, Flues, K., Scapini, K. B., Mostarda, C., Evangelista, F. de S. ’A., Rodrigues, B., et al. (2018). ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice. Clinics, 73, 01-06. doi:10.6061/clinics/2018/e246
    • NLM

      Moraes OA de, Flues K, Scapini KB, Mostarda C, Evangelista F de S’A, Rodrigues B, Dartora DR, Fiorino P, Angelis KD, Irigoyen MC. ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice [Internet]. Clinics. 2018 ; 73 01-06.Available from: http://dx.doi.org/10.6061/clinics/2018/e246
    • Vancouver

      Moraes OA de, Flues K, Scapini KB, Mostarda C, Evangelista F de S’A, Rodrigues B, Dartora DR, Fiorino P, Angelis KD, Irigoyen MC. ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice [Internet]. Clinics. 2018 ; 73 01-06.Available from: http://dx.doi.org/10.6061/clinics/2018/e246

    Referências citadas na obra
    1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Sobrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86((4)):1343–6. http://dx.doi.org/10.1172/JCI114844 [PMC free article] [PubMed]
    2. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, Witteman JC. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke. 2003;34((7)):1634–9. http://dx.doi.org/10.1161/01.STR.0000077926.49330.64 [PubMed]
    3. Celentano A, Mancini FP, Crivaro M, Palmieri V, Ferrara LA, De Stefano V, et al. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol. 1999;83((8)):1196–200. http://dx.doi.org/10.1016/S0002-9149(99)00058-2 [PubMed]
    4. Bahramali E, Rajabi M, Jamshidi J, Mousavi SM, Zarghami M, Manafi A, et al. Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study. BMJ Open. 2016;6((2)):e010282. http://dx.doi.org/10.1136/bmjopen-2015-010282 [PMC free article] [PubMed]
    5. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant. 2000;15((7)):1008–13. http://dx.doi.org/10.1093/ndt/15.7.1008 [PubMed]
    6. Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens. 2005;23((3)):463–73. http://dx.doi.org/10.1097/01.hjh.0000160198.05416.72 [PubMed]
    7. DREAM Trial Investigators. Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, et al. Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006;355((15)):1551–62. http://dx.doi.org/10.1056/NEJMoa065061 [PubMed]
    8. Ball SG. The sympathetic nervous system and converting enzyme inhibition. J Cardiovasc Pharmacol. 1989;13(Suppl 3):S17–21. [PubMed]
    9. Bertoncello N, Moreira RP, Arita DY, Aragão DS, Watanabe IK, Dantas PS, et al. Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin. J Diabetes Res. 2015;2015:674047. http://dx.doi.org/10.1155/2015/674047 [PMC free article] [PubMed]
    10. Huang W, Gallois Y, Bouby N, Bruneval P, Heudes D, Belair MF, et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci U S A. 2001;98((23)):13330–4. http://dx.doi.org/10.1073/pnas.231476798 [PMC free article] [PubMed]
    11. Ceroni A, Moreira ED, Mostarda CT, Silva GJ, Krieger EM, Irigoyen MC. Ace gene dosage influences the development of renovascular hypertension. Clin Exp Pharmacol Physiol. 2010;37((4)):490–5. http://dx.doi.org/10.1111/j.1440-1681.2009.05330.x [PubMed]
    12. Abuissa H, Bel DS, O'Keefe JH., Jr Strategies to prevent type 2 diabetes. Curr Med Res Opin. 2005;21((7)):1107–14. http://dx.doi.org/10.1185/030079905X50606 [PubMed]
    13. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol. 2004;15((3)):524–37. http://dx.doi.org/10.1097/01.ASN.0000113320.57127.B9 [PubMed]
    14. Krege JH, Kim HS, Moyer JS, Jennette JC, Peng L, Hiller SK, et al. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension. 1997;29((1 Pt 2)):150–7. http://dx.doi.org/10.1161/01.HYP.29.1.150 [PubMed]
    15. Thireau J, Zhang BL, Poisson D, Babuty D. Heart rate variability in mice: a theoretical and practical guide. Exp Physiol. 2008;93((1)):83–94. http://dx.doi.org/10.1113/expphysiol.2007.040733 [PubMed]
    16. Leehey DJ, Singh AK, Alavi N, Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl. 2000;77:S93–8. http://dx.doi.org/10.1046/j.1523-1755.2000.07715.x [PubMed]
    17. Burns KD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis. 2000;36((3)):449–67. http://dx.doi.org/10.1053/ajkd.2000.16192 [PubMed]
    18. Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, et al. Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care. 2008;31((4)):789–94. http://dx.doi.org/10.2337/dc07-1788 [PubMed]
    19. Moraes OA, Colucci JA, Souza LE, Scapini KB, Moraes-Silva IC, Mostarda C, et al. Cardiovascular autonomic dysfunction in non-obese diabetic mice. Auton Neurosci. 2013;177((2)):143–7. http://dx.doi.org/10.1016/j.autneu.2013.03.011 [PubMed]
    20. Huang J, Yamashiro Y, Papke CL, Ikeda Y, Lin Y, Patel M, et al. Angiotensin-Converting Enzyme-Induced Activation of Local Angiotensin Signaling Is Required for Ascending Aortic Aneurysms in Fibulin-4-Deficient Mice. Sci Transl Med. 2013;5((183)):183ra58. http://dx.doi.org/10.1126/scitranslmed.3005025 [PMC free article] [PubMed]
    21. De Angelis K, Schaan BD, Maeda CY, Dall'Ago P, Wichi RB, Irigoyen MC. Cardiovascular control in experimental diabetes. Braz J Med Biol Res. 2002;35((9)):1091–100. http://dx.doi.org/10.1590/S0100-879X2002000900010 [PubMed]
    22. De Angelis K, Irigoyen MC, Morris M. Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci. 2009;145((1-2)):3–10. http://dx.doi.org/10.1016/j.autneu.2008.10.013 [PMC free article] [PubMed]
    23. Malliani A, Montano N. Emerging excitatory role of cardiovascular sympathetic afferents in pathophysiological conditions. Hypertension. 2002;39((1)):63–8. http://dx.doi.org/10.1161/hy0102.099200 [PubMed]
    24. Folli F, Saad MJ, Velloso L, Hansen H, Carandente O, Feener EP, et al. Crosstalk between insulin and angiotensin II signalling systems. Exp Clin Endocrinol Diabetes. 1999;107((2)):133–9. http://dx.doi.org/10.1055/s-0029-1212088 [PubMed]
    25. Heimann AS, Favarato MH, Gozzo FC, Rioli V, Carreno FR, Eberlin MN, et al. ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight. Physiol Genomics. 2005;20((2)):173–82. http://dx.doi.org/10.1152/physiolgenomics.00145.2004 [PubMed]
    26. DiBona GF. Nervous Kidney. Interaction Between Renal Sympathetic Nerves and the Renin-Angiotensin System in the Control of Renal Function. Hypertension. 2000;36((6)):1083–8. http://dx.doi.org/10.1161/01.HYP.36.6.1083 [PubMed]
    27. Huang WC, Fang TC, Cheng JT. Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats. Hypertension. 1998;32((2)):249–54. http://dx.doi.org/10.1161/01.HYP.32.2.249 [PubMed]
    28. Simon OR, Schramm LP. The spinal course and medullary termination of myelinated renal afferents in the rat. Brain Res. 1984;290((2)):239–47. http://dx.doi.org/10.1016/0006-8993(84)90941-7 [PubMed]
    29. Farah Vde M, De Angelis K, Joaquim LF, Candido GO, Bernardes N, Fazan R, Jr, et al. Autonomic modulation of arterial pressure and heart rate variability in hypertensive diabetic rats. Clinics. 2007;62((4)):477–82. http://dx.doi.org/10.1590/S1807-59322007000400015 [PubMed]
    30. Ferrari MD, Saxena PR. Clinical effects and mechanism of action of sumatriptan in migraine. Clin Neurol Neurosurg. 1992;94(Suppl):S73–7. http://dx.doi.org/10.1016/0303-8467(92)90028-2 [PubMed]
    31. Bakris GL, Ruilope L, Locatelli F, Ptaszynska A, Pieske B, de Champlain J, et al. Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int. 2007;72((7)):879–85. http://dx.doi.org/10.1038/sj.ki.5002455 [PubMed]
    32. Navar LG, Harrison-Bernard LM, Imig JD, Wang CT, Cervenka L, Mitchell KD. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade. J Am Soc Nephrol. 1999;10(Suppl 12):S266–72. [PubMed]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020